These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Substrate specificity of the flavoprotein trypanothione disulfide reductase from Crithidia fasciculata. Henderson GB; Fairlamb AH; Ulrich P; Cerami A Biochemistry; 1987 Jun; 26(11):3023-7. PubMed ID: 3607007 [TBL] [Abstract][Full Text] [Related]
28. Enzymes of the trypanothione metabolism as targets for antitrypanosomal drug development. Schmidt A; Krauth-Siegel RL Curr Top Med Chem; 2002 Nov; 2(11):1239-59. PubMed ID: 12171583 [TBL] [Abstract][Full Text] [Related]
29. Synthesis of substrate analogues for trypanothione reductase. el-Waer AF; Benson T; Douglas KT Int J Pept Protein Res; 1993 Feb; 41(2):141-6. PubMed ID: 8458687 [TBL] [Abstract][Full Text] [Related]
30. Substrate interactions between trypanothione reductase and N1-glutathionylspermidine disulphide at 0.28-nm resolution. Bailey S; Smith K; Fairlamb AH; Hunter WN Eur J Biochem; 1993 Apr; 213(1):67-75. PubMed ID: 8477734 [TBL] [Abstract][Full Text] [Related]
31. Characterization of glutathione amide reductase from Chromatium gracile. Identification of a novel thiol peroxidase (Prx/Grx) fueled by glutathione amide redox cycling. Vergauwen B; Pauwels F; Jacquemotte F; Meyer TE; Cusanovich MA; Bartsch RG; Van Beeumen JJ J Biol Chem; 2001 Jun; 276(24):20890-7. PubMed ID: 11399772 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of substrate analogue inhibitors of trypanothione reductase. Duyzend MH; Clark CT; Simmons SL; Johnson WB; Larson AM; Leconte AM; Wills AW; Ginder-Vogel M; Wilhelm AK; Czechowicz JA; Alberg DG J Enzyme Inhib Med Chem; 2012 Dec; 27(6):784-94. PubMed ID: 22085139 [TBL] [Abstract][Full Text] [Related]
33. Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures. Benson TJ; McKie JH; Garforth J; Borges A; Fairlamb AH; Douglas KT Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):9-11. PubMed ID: 1355650 [TBL] [Abstract][Full Text] [Related]
35. Trypanothione reductase from Trypanosoma cruzi. Purification and characterization of the crystalline enzyme. Krauth-Siegel RL; Enders B; Henderson GB; Fairlamb AH; Schirmer RH Eur J Biochem; 1987 Apr; 164(1):123-8. PubMed ID: 3549299 [TBL] [Abstract][Full Text] [Related]
36. Preparative enzymatic synthesis of trypanothione and trypanothione analogues. Comini MA; Dirdjaja N; Kaschel M; Krauth-Siegel RL Int J Parasitol; 2009 Aug; 39(10):1059-62. PubMed ID: 19477177 [TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design. Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968 [TBL] [Abstract][Full Text] [Related]
38. Specific peptide inhibitors of trypanothione reductase with backbone structures unrelated to that of substrate: potential rational drug design lead frameworks. McKie JH; Garforth J; Jaouhari R; Chan C; Yin H; Besheya T; Fairlamb AH; Douglas KT Amino Acids; 2001; 20(2):145-53. PubMed ID: 11332449 [TBL] [Abstract][Full Text] [Related]